|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bouquot JE and Whitaker SB: Oral
leukoplakia - rationale for diagnosis and prognosis of its clinical
subtypes or 'phases'. Quintessence Int. 25:133–140. 1994.PubMed/NCBI
|
|
3
|
Kao SY, Mao L, Jian XC, Rajan G and Yu GY:
Expert consensus on the detection and screening of oral cancer and
precancer. Chin J Dent Res. 18:79–83. 2015.PubMed/NCBI
|
|
4
|
van der Waal I, Schepman KP, van der Meij
EH and Smeele LE: Oral leukoplakia: A clinicopathological review.
Oral Oncol. 33:291–301. 1997. View Article : Google Scholar
|
|
5
|
Vohra F, Al-Kheraif AA, Qadri T, Hassan
MI, Ahmed A, Warnakulasuriya S and Javed F: Efficacy of
photodynamic therapy in the management of oral premalignant
lesions. A systematic review. Photodiagn Photodyn Ther. 12:150–159.
2015. View Article : Google Scholar
|
|
6
|
Bewley AF and Farwell DG: Oral leukoplakia
and oral cavity squamous cell carcinoma. Clin Dermatol. 35:461–467.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barker HE, Paget JT, Khan AA and
Harrington KJ: The tumour microenvironment after radiotherapy:
Mechanisms of resistance and recurrence. Nat Rev Cancer.
15:409–425. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Au Yeung CL, Co NN, Tsuruga T, Yeung TL,
Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, et al: Exosomal
transfer of stroma-derived miR21 confers paclitaxel resistance in
ovarian cancer cells through targeting APAF1. Nat Commun.
7:111502016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hui L and Chen Y: Tumor microenvironment:
Sanctuary of the devil. Cancer Lett. 368:7–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poggi A, Musso A, Dapino I and Zocchi MR:
Mechanisms of tumor escape from immune system: Role of mesenchymal
stromal cells. Immunol Lett. 159:55–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poggi A and Giuliani M: Mesenchymal
stromal cells can regulate the immune response in the tumor
microenvironment. Vaccines (Basel). 4. pp. 42016
|
|
12
|
Klopp AH, Gupta A, Spaeth E, Andreeff M
and Marini F III: Concise review: Dissecting a discrepancy in the
literature: do mesenchymal stem cells support or suppress tumor
growth? Stem Cells. 29:11–19. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khakoo AY, Pati S, Anderson SA, Reid W,
Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, et al:
Human mesenchymal stem cells exert potent antitumorigenic effects
in a model of Kaposi's sarcoma. J Exp Med. 203:1235–1247. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Cao F, De A, Cao Y, Contag C,
Gambhir SS, Wu JC and Chen X: Trafficking mesenchymal stem cell
engraftment and differentiation in tumor-bearing mice by
bioluminescence imaging. Stem Cells. 27:1548–1558. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rhee KJ, Lee JI and Eom YW: Mesenchymal
Stem Cell-Mediated Effects of Tumor Support or Suppression. Int J
Mol Sci. 16:30015–30033. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boink MA, van den Broek LJ, Roffel S,
Nazmi K, Bolscher JG, Gefen A, Veerman EC and Gibbs S: Different
wound healing properties of dermis, adipose, and gingiva
mesenchymal stromal cells. Wound Repair Regen. 24:100–109. 2016.
View Article : Google Scholar
|
|
17
|
Xu X, Chen C, Akiyama K, Chai Y, Le AD,
Wang Z and Shi S: Gingivae contain neural-crest- and
mesoderm-derived mesen-chymal stem cells. J Dent Res. 92:825–832.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Melzer C, von der Ohe J and Hass R:
Concise Review: Crosstalk of mesenchymal stroma/stem-like cells
with cancer cells Provides therapeutic potential. Stem Cells.
36:951–968. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue X, Wang X, Zhao Y, Hu R and Qin L:
Exosomal miR-93 promotes proliferation and invasion in
hepatocellular carcinoma by directly inhibiting
TIMP2/TP53INP1/CDKN1A. Biochem Biophys Res Commun. 502:515–521.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JE, Eom JS, Kim WY, Jo EJ, Mok J, Lee
K, Kim KU, Park HK, Lee MK and Kim MH: Diagnostic value of
microRNAs derived from exosomes in bronchoalveolar lavage fluid of
early-stage lung adenocarcinoma: A pilot study. Thorac Cancer.
9:911–915. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gong L, Bao Q, Hu C, Wang J, Zhou Q, Wei
L, Tong L, Zhang W and Shen Y: Exosomal miR-675 from metastatic
osteosarcoma promotes cell migration and invasion by targeting
CALN1. Biochem Biophys Res Commun. 500:170–176. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colombo M, Raposo G and Théry C:
Biogenesis, secretion, and intercellular interactions of exosomes
and other extracellular vesicles. Annu Rev Cell Dev Biol.
30:255–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sohn W, Kim J, Kang SH, Yang SR, Cho JY,
Cho HC, Shim SG and Paik YH: Serum exosomal microRNAs as novel
biomarkers for hepatocellular carcinoma. Exp Mol Med. 47:e1842015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tengda L, Shuping L, Mingli G, Jie G, Yun
L, Weiwei Z and Anmei D: Serum exosomal microRNAs as potent
circulating biomarkers for melanoma. Melanoma Res. 28:295–303.
2018.PubMed/NCBI
|
|
25
|
Machida T, Tomofuji T, Ekuni D, Maruyama
T, Yoneda T, Kawabata Y, Mizuno H, Miyai H, Kunitomo M and Morita
M: MicroRNAs in salivary exosome as potential biomarkers of aging.
Int J Mol Sci. 16:21294–21309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji X, Zhang Z, Han Y, Song J, Xu X, Jin J,
Su S, Mu D, Liu X, Xu S, et al: Mesenchymal stem cells derived from
normal gingival tissue inhibit the proliferation of oral cancer
cells in vitro and in vivo. Int J Oncol. 49:2011–2022. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang WW, Yang LQ, Zhao F, Chen CW, Xu LH,
Fu J, Li SL and Ge XY: Epiregulin promotes lung metastasis of
salivary adenoid cystic carcinoma. Theranostics. 7:3700–3714. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fischer AH, Jacobson KA, Rose J and Zeller
R: Hematoxylin and eosin staining of tissue and cell sections. CSH
Protoc. 2008. pdb prot4986. 2008
|
|
29
|
Rio DC, Ares M Jr, Hannon GJ and Nilsen
TW: Purification of RNA using TRIzol (TRI reagent). Cold Spring
Harb Protoc. 2010:pdb prot5439. 2010. View Article : Google Scholar
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Yin H and Killeen K: The fundamental
aspects and applications of Agilent HPLC-Chip. J Sep Sci.
30:1427–1434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
López-Romero P: Pre-processing and
differential expression analysis of Agilent microRNA arrays using
the AgiMicroRna Bioconductor library. BMC Genomics. 12:642011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sinevici N and O'sullivan J: Oral cancer:
Deregulated molecular events and their use as biomarkers. Oral
Oncol. 61:12–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Verma R, Singh A, Jaiswal R, Chandra A,
Verma R and Tak J: Association of Ki-67 antigen and p53 protein at
invasive tumor front of oral squamous cell carcinoma. Indian J
Pathol Microbiol. 57:553–557. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang M, Li J, Wang L, Tian Z, Zhang P, Xu
Q, Zhang C, Wei F and Chen W: Prognostic significance of p21, p27
and survivin protein expression in patients with oral squamous cell
carcinoma. Oncol Lett. 6:381–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tkach M and Théry C: Communication by
extracellular vesicles: Where we are and where we need to go. Cell.
164:1226–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Warnakulasuriya S and Ariyawardana A:
Malignant transformation of oral leukoplakia: A systematic review
of observational studies. J Oral Pathol Med. 45:155–166. 2016.
View Article : Google Scholar
|
|
39
|
Chen X and Zhao Y: Human papillomavirus
infection in oral potentially malignant disorders and cancer. Arch
Oral Biol. 83:334–339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Singla S, Singla G, Zaheer S, Rawat DS and
Mandal AK: Expression of p53, epidermal growth factor receptor,
c-erbB2 in oral leukoplakias and oral squamous cell carcinomas. J
Cancer Res Ther. 14:388–393. 2018.PubMed/NCBI
|
|
41
|
Yuan Y, Jiang YC, Sun CK and Chen QM: Role
of the tumor microenvironment in tumor progression and the clinical
applications (Review). Oncol Rep. 35:2499–2515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hass R: Retrodifferentiation - a mechanism
for cellular regeneration? Biol Chem. 390:409–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cortini M, Massa A, Avnet S, Bonuccelli G
and Baldini N: Tumor-activated mesenchymal stromal cells promote
osteosarcoma stemness and migratory potential via IL-6 secretion.
PLoS One. 11:e01665002016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Melzer C, Yang Y and Hass R: Interaction
of MSC with tumor cells. Cell Commun Signal. 14:202016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Majore I, Moretti P, Hass R and Kasper C:
Identification of subpopulations in mesenchymal stem cell-like
cultures from human umbilical cord. Cell Commun Signal. 7:62009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kourembanas S: Exosomes: Vehicles of
intercellular signaling, biomarkers, and vectors of cell therapy.
Annu Rev Physiol. 77:13–27. 2015. View Article : Google Scholar
|
|
47
|
Cocucci E, Racchetti G and Meldolesi J:
Shedding microvesicles: Artefacts no more. Trends Cell Biol.
19:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sharma A: Role of stem cell derived
exosomes in tumor biology. Int J Cancer. 142:1086–1092. 2018.
View Article : Google Scholar
|
|
49
|
Shi S, Zhang Q, Xia Y, You B, Shan Y, Bao
L, Li L, You Y and Gu Z: Mesenchymal stem cell-derived exosomes
facilitate nasopharyngeal carcinoma progression. Am J Cancer Res.
6:459–472. 2016.PubMed/NCBI
|
|
50
|
Schepers K, Campbell TB and Passegué E:
Normal and leukemic stem cell niches: Insights and therapeutic
opportunities. Cell Stem Cell. 16:254–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Richards KE, Zeleniak AE, Fishel ML, Wu J,
Littlepage LE and Hill R: Cancer-associated fibroblast exosomes
regulate survival and proliferation of pancreatic cancer cells.
Oncogene. 36:1770–1778. 2017. View Article : Google Scholar :
|
|
52
|
Wang B, Yao K, Huuskes BM, Shen HH, Zhuang
J, Godson C, Brennan EP, Wilkinson-Berka JL, Wise AF and Ricardo
SD: Mesenchymal stem cells deliver exogenous microRNA-let7c via
exosomes to attenuate renal fibrosis. Mol Ther. 24:1290–1301. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Phinney DG and Pittenger MF: Concise
Review: MSC-derived exosomes for cell-free therapy. Stem Cells.
35:851–858. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hannafon BN and Ding WQ: Intercellular
communication by exosome-derived microRNAs in cancer. Int J Mol
Sci. 14:14240–14269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang M, Zhao C, Shi H, Zhang B, Zhang L,
Zhang X, Wang S, Wu X, Yang T, Huang F, et al: Deregulated
microRNAs in gastric cancer tissue-derived mesenchymal stem cells:
Novel biomarkers and a mechanism for gastric cancer. Br J Cancer.
110:1199–1210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gajos-Michniewicz A, Duechler M and Czyz
M: MiRNA in melanoma-derived exosomes. Cancer Lett. 347:29–37.
2014. View Article : Google Scholar : PubMed/NCBI
|
